or Try an Advanced Search...

    Technical Analysis for IMMP - Immutep Limited

    Grade Last Price % Change Price Change
    F 1.88 -4.08% -0.08
    IMMP closed down 2.97 percent on Wednesday, November 20, 2024, on 67 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical IMMP trend table...
    Date Alert Name Type % Chg
    New Downtrend Bearish -4.08%
    20 DMA Support Bullish -4.08%
    Calm After Storm Range Contraction -6.93%
    NR7 Range Contraction -6.93%
    BB Squeeze Ended Range Expansion -6.93%
    Gapped Up Strength -6.93%
    20 DMA Support Bullish -4.57%
    Bollinger Band Squeeze Range Contraction -4.57%
    Calm After Storm Range Contraction -4.57%
    Gapped Down Weakness -4.57%
    Older End-of-Day Signals for IMMP ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 3 hours ago
    1.5x Volume Pace about 3 hours ago
    Down 5% about 3 hours ago
    Down 1 ATR about 3 hours ago
    Gap Down Partially Closed about 3 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    IMMP Chart by TradingView
    Basic chart:

    Profile

    Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Autoimmune Disease Therapeutic Products

    Is IMMP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients
    Nov 14 Immutep stock jumps 11% on positive data for eftilagimod alpha
    Nov 14 Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
    Nov 14 Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
    Nov 14 Positive Data from Phase II Trial in Soft Tissue Sarcoma Presented at CTOS 2024 Annual Meeting
    Nov 6 Immutep (ASX:IMM) shareholders have endured a 51% loss from investing in the stock three years ago
    Oct 29 Immutep Quarterly Activities Report Q1 FY25
    Oct 28 Immutep to Present New Phase IIb Data in PD-L1 Negative (CPS <1) Head and Neck Cancer at ESMO Immuno-Oncology 2024
    Oct 17 Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial
    Oct 10 Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit
    See more IMMP news...

    Comments

    S

    SociableGnat503 over 1 year ago

    Any thoughts on what to expect here based on the chart? The volume looks quite low here. 

    0 Reply
    T

    TraderMike over 1 year ago

    looks range-bound to me

    0 Reply
    S

    SociableGnat503 over 1 year ago

    What does that mean, short term pain but long term gain? 

    0 Reply
    T

    TraderMike over 1 year ago

    It means it's stuck in a range -- going sideways between about 1.9 & 2.4

    0 Reply
    S

    SociableGnat503 about 1 year ago

    One can hope that it will ultimately pop given the potential and cash runway. 

    0 Reply
    T

    TraderMike about 1 year ago

    Hope is not a plan 😁

    0 Reply
    S

    SociableGnat503 about 1 year ago

    It's why I will never be rich....lol 

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.335
    52 Week Low 1.58
    Average Volume 110,006
    200-Day Moving Average 2.34
    50-Day Moving Average 2.06
    20-Day Moving Average 1.92
    10-Day Moving Average 1.96
    Average True Range 0.12
    RSI (14) 48.98
    ADX 25.94
    +DI 21.52
    -DI 24.20
    Chandelier Exit (Long, 3 ATRs) 1.82
    Chandelier Exit (Short, 3 ATRs) 2.12
    Upper Bollinger Bands 2.08
    Lower Bollinger Band 1.76
    Percent B (%b) 0.64
    BandWidth 16.81
    MACD Line -0.01
    MACD Signal Line -0.04
    MACD Histogram 0.0241
    Fundamentals Value
    Market Cap 233.01 Million
    Num Shares 119 Million
    EPS -0.35
    Price-to-Earnings (P/E) Ratio -5.60
    Price-to-Sales 81.76
    Price-to-Book 3.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.14
    Resistance 3 (R3) 2.14 2.09 2.11
    Resistance 2 (R2) 2.09 2.04 2.09 2.10
    Resistance 1 (R1) 2.02 2.01 2.00 2.02 2.09
    Pivot Point 1.97 1.97 1.95 1.97 1.97
    Support 1 (S1) 1.90 1.92 1.88 1.90 1.83
    Support 2 (S2) 1.85 1.89 1.85 1.82
    Support 3 (S3) 1.78 1.85 1.81
    Support 4 (S4) 1.78